143 related articles for article (PubMed ID: 18952634)
1. Immediate improvement in coronary flow reserve after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.
Jaber WA; Yang EH; Nishimura RA; Sorajja P; Rihal CS; Elesber A; Eeckhout E; Lerman A
Heart; 2009 Apr; 95(7):564-9. PubMed ID: 18952634
[TBL] [Abstract][Full Text] [Related]
2. Effect of successful alcohol septal ablation on microvascular function in patients with obstructive hypertrophic cardiomyopathy.
Soliman OI; Geleijnse ML; Michels M; Dijkmans PA; Nemes A; van Dalen BM; Vletter WB; Serruys PW; ten Cate FJ
Am J Cardiol; 2008 May; 101(9):1321-7. PubMed ID: 18435965
[TBL] [Abstract][Full Text] [Related]
3. Regional difference of microcirculation in patients with asymmetric hypertrophic cardiomyopathy: transthoracic Doppler coronary flow velocity reserve analysis.
Tesic M; Djordjevic-Dikic A; Beleslin B; Trifunovic D; Giga V; Marinkovic J; Petrovic O; Petrovic M; Stepanovic J; Dobric M; Vukcevic V; Stankovic G; Seferovic P; Ostojic M; Vujisic-Tesic B
J Am Soc Echocardiogr; 2013 Jul; 26(7):775-82. PubMed ID: 23643850
[TBL] [Abstract][Full Text] [Related]
4. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
[TBL] [Abstract][Full Text] [Related]
5. Comparison of diastolic septal perforator flow velocities in hypertrophic cardiomyopathy versus hypertensive left ventricular hypertrophy.
Sherrrid MV; Mahenthiran J; Casteneda V; Fincke R; Gasser M; Barac I; Thayaparan R; Chaudhry FA
Am J Cardiol; 2006 Jan; 97(1):106-12. PubMed ID: 16377293
[TBL] [Abstract][Full Text] [Related]
6. [Assessment of coronary flow reserve in patients with hypertrophic cardiomyopathy using transthoracic color Doppler echocardiography].
Asami Y; Yoshida K; Hozumi T; Akasaka T; Takagi T; Kaji S; Kawamoto T; Ogata Y; Yagi T; Morioka S; Yoshikawa J
J Cardiol; 1998 Oct; 32(4):247-52. PubMed ID: 9833231
[TBL] [Abstract][Full Text] [Related]
7. Coronary flow reserve impairment in apical vs asymmetrical septal hypertrophic cardiomyopathy.
Ahn HS; Kim HK; Park EA; Lee W; Kim YJ; Cho GY; Park JH; Sohn DW
Clin Cardiol; 2013 Apr; 36(4):207-16. PubMed ID: 23378014
[TBL] [Abstract][Full Text] [Related]
8. Right ventricular energetics in patients with hypertrophic cardiomyopathy and the effect of alcohol septal ablation.
Timmer SA; Knaapen P; Germans T; Lubberink M; Dijkmans PA; Vonk-Noordegraaf A; Ten Berg JM; Ten Cate FJ; Lammertsma AA; van Rossum AC
J Card Fail; 2011 Oct; 17(10):827-31. PubMed ID: 21962421
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous transluminal septal artery ablation using polyvinyl alcohol foam particles for septal hypertrophy in patients with hypertrophic obstructive cardiomyopathy: acute and 3-year outcomes.
Gross CM; Schulz-Menger J; Krämer J; Siegel I; Pilz B; Waigand J; Friedrich MG; Uhlich F; Dietz R
J Endovasc Ther; 2004 Dec; 11(6):705-11. PubMed ID: 15615561
[TBL] [Abstract][Full Text] [Related]
10. Diastolic coronary vascular reserve: a new index to detect changes in the coronary microcirculation in hypertrophic cardiomyopathy.
Krams R; Ten Cate FJ; Carlier SG; Van Der Steen AF; Serruys PW
J Am Coll Cardiol; 2004 Feb; 43(4):670-7. PubMed ID: 14975481
[TBL] [Abstract][Full Text] [Related]
11. [Doppler echocardiographic evaluation of left ventricular diastolic function in patients with hypertrophic obstructive cardiomyopathy after alcohol septal ablation in acute and long-term follow up].
Wojtarowicz A; Kornacewicz-Jach Z; Kaźmierczak J; Szamlewski P; Gil R; Lewandowski M
Pol Merkur Lekarski; 2002 Jul; 13(73):25-8. PubMed ID: 12362500
[TBL] [Abstract][Full Text] [Related]
12. Alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in patients with prior coronary revascularization.
Khouzam RN; Naidu SS
J Invasive Cardiol; 2010 Dec; 22(12):E220-4. PubMed ID: 21127375
[TBL] [Abstract][Full Text] [Related]
13. Relation of immediate decrease in ventricular septal strain after alcohol septal ablation for obstructive hypertrophic cardiomyopathy to long-term reduction in left ventricular outflow tract pressure gradient.
van Ramshorst J; Mollema SA; Delgado V; van der Wall EE; Schalij MJ; Atsma DE; Bax JJ
Am J Cardiol; 2009 Jun; 103(11):1592-7. PubMed ID: 19463521
[TBL] [Abstract][Full Text] [Related]
14. Effect of septal ablation on myocardial relaxation and left atrial pressure in hypertrophic cardiomyopathy an invasive hemodynamic study.
Sorajja P; Nishimura RA; Ommen SR; Rihal CS; Gersh BJ; Holmes DR
JACC Cardiovasc Interv; 2008 Oct; 1(5):552-60. PubMed ID: 19463358
[TBL] [Abstract][Full Text] [Related]
15. Sustained improvement in left ventricular diastolic function after alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
Jassal DS; Neilan TG; Fifer MA; Palacios IF; Lowry PA; Vlahakes GJ; Picard MH; Yoerger DM
Eur Heart J; 2006 Aug; 27(15):1805-10. PubMed ID: 16774986
[TBL] [Abstract][Full Text] [Related]
16. Cyanoacrylate for septal ablation in hypertrophic cardiomyopathy.
Oto A; Aytemir K; Okutucu S; Kaya EB; Deniz A; Cil B; Peynircioglu B; Kabakci G
J Interv Cardiol; 2011 Feb; 24(1):77-84. PubMed ID: 20973822
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and three-year noninvasive follow-up in 18 patients.
Guo H; Wang J; Chen J; Shan J; Lee JD; Ueda T
Can J Cardiol; 2004 Jun; 20(8):779-82. PubMed ID: 15229758
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy.
Seggewiss H; Faber L; Gleichmann U
Thorac Cardiovasc Surg; 1999 Apr; 47(2):94-100. PubMed ID: 10363608
[TBL] [Abstract][Full Text] [Related]
19. Changes in phasic coronary blood flow velocity profile and relative coronary flow reserve in patients with hypertrophic obstructive cardiomyopathy.
Kyriakidis MK; Dernellis JM; Androulakis AE; Kelepeshis GA; Barbetseas J; Anastasakis AN; Trikas AG; Tentolouris CA; Gialafos JE; Toutouzas PK
Circulation; 1997 Aug; 96(3):834-41. PubMed ID: 9264490
[TBL] [Abstract][Full Text] [Related]
20. Effects of alcohol septal ablation for hypertrophic obstructive cardiomyopathy on Doppler Tei index: a midterm follow-up.
Veselka J; Procházková S; Bolomová-Homolová I; Duchonová R; Tesar D
Echocardiography; 2005 Feb; 22(2):105-9. PubMed ID: 15693775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
